Grant: CIHR Fellowship
Direct Payment
$150,000.00
Defining the Role of Metabolism in Cell State Reprogramming: Systems and Synthetic Biology Approaches.
EF 2010-11
Résumé
The history of medical research is punctuated by key discoveries that have transformed the course of human health. In the 1960s, Canadian researchers identified the first stem cells in bone marrow, and since this first discovery, stem cells have been found throughout the body. During embryonic development, stem cells serve as the "seeds" for organ growth and later, adult stem cells serve to repair and maintain the body. Recent work has shown that adult skin cells can be "rebooted" back to a state virtually identical to embryonic stem cells. Such cells have the potential to be redirected into any other cell type in the body, such as neurons or heart muscle. This breakthrough demonstrates that cell state can be engineered, and promises to bring revolutionary changes to human health.
While these techniques have been successful in the lab, there are several technical barriers to the safe and reliable use of these cells in medicine. In their current state, these methods are inefficient and slow, and use a viral method that increases the risk of cancer. This project aims to improve the speed and efficiency of the methods by mapping cell regulatory pathways before, during and after reprogramming. This map will then be used as guide to find more direct routes between cell states.
Drawing further inspiration from nature, we are replacing the current method with a virus-free approach using molecules that naturally direct cell fate during development, mRNA and metabolites. These molecules leave the genome untouched and thus do not increase the risk of cancer. Results from early trials of our virus-free protocols have been successful, and, when combined with the more direct routes described above, promise to advance the next generation of reprogramming technology. Such stem cells would open the door for incredible medical advances, including patient-specific regenerative medicine, more relevant drug discovery and research into complex disease processes.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
226119
Name
Pardee Keith I
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Defining the Role of Metabolism in Cell State Reprogramming: Systems and Synthetic Biology Approaches.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cell State Transitions; Cellular Reprogramming; Chemical Biology; Developmental Biology; Gene Regulation/Expression; Induced Pluripotent Stem Cells; Metabolomics; Regenerative Medicine; Regulatory Networks
Abstract
The history of medical research is punctuated by key discoveries that have transformed the course of human health. In the 1960s, Canadian researchers identified the first stem cells in bone marrow, and since this first discovery, stem cells have been found throughout the body. During embryonic development, stem cells serve as the "seeds" for organ growth and later, adult stem cells serve to repair and maintain the body. Recent work has shown that adult skin cells can be "rebooted" back to a state virtually identical to embryonic stem cells. Such cells have the potential to be redirected into any other cell type in the body, such as neurons or heart muscle. This breakthrough demonstrates that cell state can be engineered, and promises to bring revolutionary changes to human health.
While these techniques have been successful in the lab, there are several technical barriers to the safe and reliable use of these cells in medicine. In their current state, these methods are inefficient and slow, and use a viral method that increases the risk of cancer. This project aims to improve the speed and efficiency of the methods by mapping cell regulatory pathways before, during and after reprogramming. This map will then be used as guide to find more direct routes between cell states.
Drawing further inspiration from nature, we are replacing the current method with a virus-free approach using molecules that naturally direct cell fate during development, mRNA and metabolites. These molecules leave the genome untouched and thus do not increase the risk of cancer. Results from early trials of our virus-free protocols have been successful, and, when combined with the more direct routes described above, promise to advance the next generation of reprogramming technology. Such stem cells would open the door for incredible medical advances, including patient-specific regenerative medicine, more relevant drug discovery and research into complex disease processes.
Competitiondate
201102
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Pardee, Keith I
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~